Candriam Equities L Biotechnology Class I USD CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/06/2024 |
|
Annual Returns (GBP) | 30/06/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/06 | |
Price Return | 15.50 | -4.57 | 28.56 | 17.57 | -0.73 | 9.79 | 1.49 | 6.81 |
+/- Category | 5.21 | 3.39 | 8.36 | -8.40 | 8.30 | 17.62 | 2.77 | 7.36 |
+/- Category Index | 0.31 | -2.73 | 11.85 | -15.37 | -1.03 | 7.32 | -5.84 | -11.06 |
% Rank in Category | 24 | 32 | 14 | 61 | 34 | 3 | 30 | 19 |
Trailing Returns (GBP) | 15/07/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.22 | -0.11 | 0.51 |
1 Week | 4.62 | -1.19 | 3.64 |
1 Month | 6.41 | 3.57 | 4.51 |
3 Months | 12.06 | 9.19 | 0.50 |
6 Months | 7.59 | 5.79 | -8.56 |
YTD | 11.01 | 9.00 | -6.91 |
1 Year | 22.86 | 12.37 | -13.50 |
3 Years Annualised | 7.97 | 11.25 | -0.56 |
5 Years Annualised | 10.00 | 2.62 | -2.88 |
10 Years Annualised | 12.06 | 2.05 | 0.01 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/06/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.72 | 2.98 | - | - |
2023 | -5.08 | -0.50 | -0.61 | 8.11 |
2022 | -4.88 | -0.16 | 12.93 | 2.38 |
2021 | -5.73 | 6.89 | 0.69 | -2.16 |
2020 | -4.77 | 25.59 | -5.57 | 4.11 |
2019 | 13.88 | 1.56 | -5.58 | 17.73 |
|
Advertisement |